- Eisai, Inc (Nutley, NJ)
- …Medical Affairs)Eisai Salary Transparency Language:The base salary range for the Medical Director , Oncology Global Medical Affairs, HCC and GI is ... pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development....your profile, we want to hear from you. The Medical Director will provide medical … more
- Merck & Co. (Rahway, NJ)
- …(Dir GSVC-HCP) for oncology is a headquarters-based leadership role within Global Medical and Value Capabilities (GMVC) organization. The role reports ... Job DescriptionThe Director , Global Scientific and Value Content-Healthcare...The role has several key responsibilities with in the Global Medical and Scientific Affairs (GMSA) team.… more
- Eisai, Inc (Nutley, NJ)
- …a difference. If this is your profile, we want to hear from you. Associate Director , Medical Education - Oncology , is responsible for the strategic planning ... for assigned therapeutic area(s). Collaborate with other stakeholders across Global & US Medical Affairs functions and...Salary Transparency Language:The base salary range for the Associate Director , Medical Education - Oncology … more
- Eisai, Inc (Nutley, NJ)
- …is your profile, we want to hear from you. The Executive Director , Global Clinical Development resides within the Oncology at Eisai. This Executive ... vendor management, budget planning & resource management.Demonstrated track record as Study Director (or equivalent role) with Global Clinical Lead or Clinical… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... around rare diseases and immune disorders. Job Summary: A cross- Oncology Development Medical Doctor position reporting to...matrix environment and on cross-functional teams. Travel: Local and global travel might be required up to 20% Daiichi… more
- Eisai, Inc (Nutley, NJ)
- …difference. If this is your profile, we want to hear from you. The Associate Director (AD), Global Medical Affairs Training and Education is responsible for ... cross functional launch planning and other strategic initiatives for Oncology Medical Affairs. The AD will also...Salary Transparency Language:The base salary range for the Associate Director , Global Medical Affairs Training… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …drive the implementation of a quality strategy and quality plan closely aligned with the Global Oncology Medical Affairs (GOMA), Oncology Business Unit ... immune disorders. JOB SUMMARYThe Senior Director , Head Medical affairs Quality Assurance in Global RD/PV...QA leadership team. The position will represent QA at Global Oncology Medical Affairs LT,… more
- Eisai, Inc (Nutley, NJ)
- …preferred.Skills:Eisai Salary Transparency Language:The base salary range for the Executive Director , Global Regulatory Affairs - Neurology is from ... At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides...pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …new medicines to help people. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …new medicines to help people.Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Eisai, Inc (Nutley, NJ)
- At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai's human health care ... pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development....is your profile, we want to hear from you. Director , HCP Marketing, Alzheimer's Disease will lead several core… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …new medicines to help people. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …new medicines to help people. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
